MyAverix Finance
F · Healthcare
Tvardi Therapeutics Inc. (69C)
Biotechnology
Tvardi Therapeutics Inc. (69C) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 69C
Tvardi Therapeutics Inc. (69C) — FAQ
What is 69C's P/E ratio?
The price-to-earnings (P/E) ratio for Tvardi Therapeutics Inc. (69C) is 25.00 (data as of 2026-05-23).
Does Tvardi Therapeutics Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Tvardi Therapeutics Inc. (69C). Check the MyAverix Finance app for the latest dividend data.
What sector is Tvardi Therapeutics Inc. in?
Tvardi Therapeutics Inc. (69C) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 69C listed on?
69C is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.